FLR Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
FLR is not a clear buy right now for a Beginner-focused, long-term investor with $50,000-$100,000 to deploy. The stock has some constructive long-term catalysts, including a large backlog, improved cash reserves from the NuScale stake sale, and expected earnings growth, but the current setup is mixed rather than compelling. Since the investor is impatient and unwilling to wait for an optimal entry, I would not call this a strong buy at today's level. The better call is to hold and wait for a more attractive entry or clearer confirmation of momentum.
FLR is trading near short-term resistance, with price at 47.07 and R1 at 47.104, which means it is pressing into a nearby ceiling rather than breaking out decisively. MACD is positive and expanding, which supports a mild bullish trend, but RSI_6 at 60.278 is only neutral-to-moderately bullish, not overbought. Moving averages are converging, suggesting the trend is improving but not strongly established. The SwingMax signal gave an entry on 2026-05-26, and the stock is only up 1.55% since then, so the signal is still relevant but no longer a fresh low-risk entry. The short-term pattern analysis is also weak, with only a 20% chance of gains and negative expected moves over the next day, week, and month.
["Fluor sold its NuScale Power stake for about $2.4 billion, lifting cash reserves to $3.2 billion and improving financial flexibility.", "The company has a $25.7 billion backlog, giving it strong revenue visibility.", "Analysts expect earnings to grow about 15% annually over the next 3 to 5 years.", "Infrastructure demand remains supportive for Fluor's core business.", "Nuclear-related market interest is rising due to AI and data-center power demand."]
["The stock recently fell after a disappointing Q1 2026 earnings report.", "Insiders are selling, with selling activity increasing sharply over the last month.", "Hedge funds are neutral, with no meaningful accumulation trend.", "The share price is sitting just below nearby resistance, limiting immediate upside confidence.", "Short-term pattern data points to weak next-day, next-week, and next-month performance odds."]
Latest quarter referenced in the news is Q1 2026, which was disappointing and triggered the stock decline. Even so, the latest quarter context is still constructive over the longer term because the company boosted cash with the NuScale sale, now holding $3.2 billion in cash, and it has a $25.7 billion backlog. While the exact quarter financial figures were not provided, the growth outlook remains positive with analyst estimates for around 15% annual earnings growth over the next three to five years.
Analyst sentiment is mixed but still leaning constructive. On 2026-05-11, Citi lowered its price target to $56 from $61 but kept a Buy rating, saying the company has been disappointing while its awards upcycle may be nearing. On the same day, Baird raised its target to $49 from $48 but kept a Neutral rating. Overall, Wall Street is split: one bullish voice still sees upside, but another is cautious, so the pros and cons view is balanced rather than strongly positive.
